Company Registration No. 09592427 (England and Wales)
ABC Pharma Limited
Unaudited accounts
for the year ended 31 May 2025
ABC Pharma Limited
Unaudited accounts
Contents
ABC Pharma Limited
Company Information
for the year ended 31 May 2025
Directors
Alan Barnard
Jeanette Marie Barnard
Company Number
09592427 (England and Wales)
Registered Office
1 LEIGH MEADOWS
WALTON-LE-DALE
PRESTON
PR5 4DG
UNITED KINGDOM
ABC Pharma Limited
Statement of financial position
as at 31 May 2025
Tangible assets
3,379,770
2,043,430
Investment property
360,873
236,458
Cash at bank and in hand
1,649,819
2,555,650
Creditors: amounts falling due within one year
(324,788)
(495,411)
Net current assets
1,336,031
2,071,239
Net assets
5,076,674
4,351,127
Called up share capital
200
200
Profit and loss account
5,076,474
4,350,927
Shareholders' funds
5,076,674
4,351,127
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 29 May 2026 and were signed on its behalf by
Alan Barnard
Director
Company Registration No. 09592427
ABC Pharma Limited
Notes to the Accounts
for the year ended 31 May 2025
ABC Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 09592427. The registered office is 1 LEIGH MEADOWS, WALTON-LE-DALE, PRESTON, PR5 4DG, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% Reducing Balance
4
Tangible fixed assets
Land & buildings
Motor vehicles
Fixtures & fittings
Total
Cost or valuation
At cost
At cost
At cost
At 1 June 2024
1,941,356
154,019
46,564
2,141,939
Additions
1,330,000
13,083
20,361
1,363,444
At 31 May 2025
3,271,356
167,102
66,925
3,505,383
At 1 June 2024
-
68,390
30,119
98,509
Charge for the year
-
19,743
7,361
27,104
At 31 May 2025
-
88,133
37,480
125,613
At 31 May 2025
3,271,356
78,969
29,445
3,379,770
At 31 May 2024
1,941,356
85,629
16,445
2,043,430
Fair value at 1 June 2024
236,458
ABC Pharma Limited
Notes to the Accounts
for the year ended 31 May 2025
Amounts falling due within one year
Other debtors
11,000
11,000
7
Creditors: amounts falling due within one year
2025
2024
Taxes and social security
206,305
395,070
Other creditors
1,500
6,112
Loans from directors
42,497
(8,733)
8
Average number of employees
During the year the average number of employees was 2 (2024: 2).